Status:
NOT_YET_RECRUITING
A Prospective Cohort Study for Establishing Clinical Excellence in Patients With Newly Diagnosed Type 1 and Type 2 Diabetes and Prediabetes
Lead Sponsor:
Yonsei University
Conditions:
Newly Diagnosed Type 1 and Type 2 Diabetes and Prediabetes
Eligibility:
All Genders
20+ years
Brief Summary
Diabetes mellitus is recognized as a metabolic disease that causes global economic and health burdens with an estimated number of patients 135 million in 1995 to 300 million in 2025. Moreover, the Asi...
Eligibility Criteria
Inclusion
- Drug naive patients who are newly diagnosed type 1 diabetes/type 2 diabetes or prediabetes since March, 2022 in Severance hospital ② Male or female who are older than 20 years ③ Patients who consented and underwent recommended regular blood and urinary tests according to the current guidelines.
Exclusion
- ① Patients who are considered to be unable to participate in the study by the judgement of researchers
- ② Patients who are unable to read the consent forms (E.g Foreigner, illiteracy)
Key Trial Info
Start Date :
July 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2026
Estimated Enrollment :
3000 Patients enrolled
Trial Details
Trial ID
NCT05401708
Start Date
July 1 2022
End Date
May 1 2026
Last Update
June 2 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yonsei University Health System, Severance Hospital
Seoul, South Korea